- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 94 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2023
- 150 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2023
- 119 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2023
- 140 Pages
Global
From €3421EUR$3,599USD£2,874GBP
- Report
- April 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
Live cell encapsulation is a type of biomaterial technology used to protect and maintain the viability of living cells. It involves the use of a semi-permeable membrane to enclose the cells, allowing for the exchange of nutrients and waste products while preventing the cells from coming into contact with the external environment. This technology has been used in a variety of applications, including drug delivery, tissue engineering, and cell-based therapies.
Live cell encapsulation has the potential to revolutionize the field of biomedicine, as it allows for the safe and efficient delivery of therapeutic cells to the body. It also has the potential to reduce the risk of contamination and immunological rejection, as the encapsulated cells are isolated from the body’s immune system.
Some of the major players in the live cell encapsulation market include Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, Lonza Group, and NuvoCell. These companies are involved in the development and production of various encapsulation materials and systems for use in biomedical applications. Show Less Read more